Press release
Sarcopenia Market to Grow at 4.30% CAGR Through 2034
Sarcopenia Market Share
The sarcopenia market is segmented by treatment type, route of administration, end user, and distribution channel. Among treatments, protein supplements and pharmacotherapy are gaining prominence due to their established roles in muscle mass enhancement and function preservation.
From a geographic perspective, North America dominates due to a higher aging population, well-developed healthcare infrastructure, and the presence of global market leaders such as AbbVie Inc., Amgen Inc., and Pfizer Inc.. Meanwhile, Japan and the EU-4 (Germany, France, Italy, Spain) represent significant secondary markets due to increasing healthcare spending and rising awareness of sarcopenia as a clinical condition.
Get a Free Sample Report with Table of Contents - https://bitl.to/4kmr.
Sarcopenia Market Growth & Trends
Several drivers are fueling the sarcopenia market's growth trajectory:
Aging Demographics: A growing elderly population globally-particularly in developed regions-is leading to higher incidences of age-associated muscle degeneration.
Clinical Recognition of Sarcopenia: Once overlooked, sarcopenia is now increasingly recognized as a treatable medical condition. This shift is accelerating diagnosis and treatment efforts.
Nutritional Interventions: The rise of functional foods and nutraceuticals, especially those targeting muscle health, is reinforcing the need for non-pharmacologic treatment options.
Advancements in Biomarkers and Diagnostics: New diagnostic technologies for assessing muscle mass and function are enabling earlier intervention.
Preventive Healthcare Focus: The broader shift toward preventive healthcare is encouraging investments in sarcopenia screening and management programs.
Sarcopenia Market Case Studies & News
Recent industry developments showcase ongoing innovation:
In 2023, Nestlé Health Science launched a new muscle health supplement combining vitamin D, whey protein, and leucine, targeting elderly patients with early-stage sarcopenia.
Amgen Inc. partnered with biotech startups to investigate the myostatin inhibitor class of drugs aimed at increasing muscle mass.
Clinical trials in Europe and Japan are testing the efficacy of combination therapies (nutrition + pharmacotherapy) for elderly individuals showing early signs of muscle atrophy.
These developments highlight the increasing attention the condition is receiving from both pharmaceutical and nutritional science domains.
Read the Full Report with the Table of Contents - https://bitl.to/4kmq.
Sarcopenia Market Analysis
The sarcopenia market is relatively fragmented, with a mix of pharmaceutical giants, nutraceutical firms, and biotech innovators competing to address a growing patient base.
Regulatory Developments: Many countries are introducing guidelines for the clinical identification and management of sarcopenia. For example, the European Working Group on Sarcopenia in Older People (EWGSOP) has issued criteria that guide diagnosis and care strategies.
Market Dynamics: Companies that combine therapeutics with nutritional solutions are well-positioned for growth. In parallel, digital health tools are being explored for remote monitoring and early diagnosis, especially in home care settings.
To learn more about the condition and its implications, see Wikipedia's article on sarcopenia.
Sarcopenia Market Segmentation
Market Breakup by Treatment Type:
Protein Supplement - Helps boost muscle synthesis and counteract muscle loss.
Vitamin B12 Supplement - Targets common deficiencies in older adults.
Vitamin D & Calcium Supplement - Supports bone integrity and muscle function.
Pharmacotherapy - Involves prescription drugs targeting muscle mass and strength.
Others
Market Breakup by Route of Administration:
Oral - Most common and patient-friendly method.
Parenteral - Used for rapid or direct absorption via injections.
Others
Market Breakup by End User:
Hospitals - Provide inpatient diagnosis and care.
Homecare - Expanding with aging-in-place trends and remote health tools.
Specialty Clinics - Focused care centers for geriatrics or muscle disorders.
Others
Market Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Market Breakup by Region:
United States
EU-4 and the United Kingdom
Germany
France
Italy
Spain
United Kingdom
Japan
China
The United States and Japan lead the market owing to their high elderly populations and proactive geriatric healthcare programs. Europe follows closely, with ongoing awareness campaigns and supportive regulatory frameworks.
Sarcopenia Market Key Players
Prominent companies in the sarcopenia market include:
Amgen Inc.
F-Hoffmann La-Roche
American Way (Amway) Corporation
Abbott Laboratories, Inc.
AbbVie Inc.
Merck Sharp & Dohme Corp.
AstaReal AB
Pfizer Inc.
Sanofi S.A.
Nestlé Health Science
Zydus Cadila
Bayer AG
Johnson & Johnson
Novartis AG
These players are actively investing in R&D, product expansion, and strategic collaborations to gain a competitive edge in a growing yet underdiagnosed market.
Access More Reports
United States Medical Adhesives Market - https://linkd.so/3CtO.
Sjogren's Syndrome Therapeutics Market - https://linkd.so/3CtP.
Peripheral Artery Disease Market - https://linkd.so/3CtQ.
Major Depressive Disorder Treatment Market - https://linkd.so/3CtR.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcopenia Market to Grow at 4.30% CAGR Through 2034 here
News-ID: 4081356 • Views: …
More Releases from Expert Market Research
Australia Dietary Supplements Market to Grow at 8.1% CAGR
The Australia dietary supplements market is experiencing significant growth, driven by rising health awareness, aging demographics, and an increase in preventive healthcare practices. As consumers increasingly prioritize wellness and functional nutrition, the demand for dietary supplements continues to surge.
Expert Market Research projects that the market will grow at a CAGR of 8.10% during the forecast period of 2025-2034, making it one of the key segments in the country's health and…
Latin America IVD Market to Grow at 17.9% CAGR by 2034
Access the latest analysis from Expert Market Research to explore the evolving Latin America in-vitro diagnostics (IVD) industry and discover how technological advancements and rising healthcare needs are shaping this essential market segment.
Latin America In-vitro Diagnostics Market Size
The Latin America in-vitro diagnostics market has shown robust growth in recent years and is projected to continue expanding at a CAGR of 17.90% during the forecast period of 2025-2034. This significant expansion…
Mexico Aluminium Market Size, Growth & Forecast Analysis Outlook 2025-2034
The Mexico aluminium market stands as a significant pillar within the country's industrial sector, driven by rapid advancements in automotive, construction, and packaging industries. Aluminium's versatility, lightweight nature, and excellent corrosion resistance have made it indispensable across various sectors. With growing domestic manufacturing and increasing foreign investments, Mexico has evolved into a major hub for aluminium production and processing in Latin America. Strategic trade partnerships, robust infrastructure, and access to…
U.S. Crayfish Market Trends, Forecast & Growth Insights 2025-2034
The United States crayfish market is witnessing extraordinary momentum, driven by increased culinary popularity, aquaculture expansion, and evolving consumer preferences. In 2024, the market reached a value of USD 648.07 Million, and is projected to register an impressive CAGR of 31.50% during 2025-2034, ultimately reaching nearly USD 10,020.27 Million by 2034. This article explores in-depth the market overview, size, segmentation, opportunities, and competitive landscape shaping the future of the U.S.…
More Releases for Sarcopenia
The Sarcopenia Treatment Market to be digitally servile
The Sarcopenia Treatment Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent…
Sarcopenia Market Scope Emerging Trends, Analysis and Forecast 2026
The report published on the “Sarcopenia Market Scope Emerging Trends, Analysis and Forecast 2026” by Zion Market Research facilitates a closer outlook on opportunities, revenue growth, and current market trends. The report is focused to offer qualitative and quantitative analysis of dynamics and market opportunities prevailing during the forecast period. Also, the report encompasses an in-depth study on the prominent leaders in the Sarcopenia Market.
The Leading Market Players Covered…
Sarcopenia Treatment Market to Witness Significant Incremental Opportunity
According to a recent report published by Research Dive, titled, "Sarcopenia Treatment Market by Type, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025," the global Sarcopenia Treatment market size was valued at $ 2742.4 million in 2018, and is projected to reach $ 3975.0 million by 2026, registering a CAGR of 4.7% from 2018 to 2026.
North America dominates the market, followed by Europe, Asia-Pacific, Latin America, Middle East and…
Sarcopenia Treatment Market Analysis & Key Trends 2025
Sarcopenia which results in the decrease of lean muscle mass when the person reaches age thirty or above, she or he could expect the gradual loss of muscle tissues due to increasing aging altering the level of activity and also affecting the quality of life. Aging leads to change in metabolic activity which includes the decrease in synthesis of muscle protein and little change in the degradation. Sarcopenia affects…
Sarcopenia Pipeline Review H2 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Pipeline Review, H2 2017, provides an overview of the Sarcopenia (Musculoskeletal Disorders) pipeline landscape.
Sarcopenia is defined as the loss of mass and muscular function with age. Symptoms include obesity, difficulty walking or moving about, lack of strength and respiratory problems. Treatment includes medications and hormone replacement therapy.
Publisher's Pharmaceutical and Healthcare latest pipeline guide Sarcopenia - Pipeline Review, H2 2017,…
Sarcopenia Treatment Market: Upcoming Demands and Growth Analysis 2025
Sarcopenia is the loss of muscle mass and muscle strength as a person reaches age thirty or more, in response to aging, affecting the level of activity and quality of life. It has been identified in three stages in older people: presarcopenia-loss of muscle mass, sarcopenia-loss of muscle which can affect either physical performance or physical strength, and severe sarcopenia-loss of muscle mass that affects both physical performance and strength.…
